Search

everythinglearnresearchcommunity

for

Search:↓

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Physical activity, height, and smoking affect prostate cancer risk.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Male pattern baldness does not cause an increased risk of prostate cancer.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Women with alopecia may have a higher chance of getting thyroid cancer.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride does not prevent bladder cancer.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Newly made nicotinamide compounds could potentially treat cancer.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.